290 views

Venture Corporation revenue up 7.6% to $717.5m in H1 2024

A dividend payment of $0.50 has been declared.

Venture Corporation reported a net profit of $123.7m for the first six months of 2024, its latest bourse filing showed. Revenue for the period is $$1.38b.

Its interim dividend is $0.25 per share on a one-tier tax-exempt basis for Q1, and $0.426 for H1.

For Q2, Venture Corporation registered a net profit of $63.5m and a revenue of $717.5m, the latter an increase of 7.6% quarter-on-quarter (QoQ).

Cash flow improved to $153m in Q2, thanks to optimisation in its working capital, Venture Corporation said. For H1, the company recorded a cash flow of $302.3m, compared to $290.9m in H2 2023.

Its interim dividend is $0.25 per share on a one-tier tax-exempt basis for H1. This is reportedly in line with the interim dividend for the same period in 2023.

Looking ahead, Venture Capital expects its group revenue to end up stronger in H2 2024 compared to H1. 

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare